Explore 3 Stock Ideas & Industry Insights Download Free Report

KALIN®

Heartland Group Holdings Limited

Jul 15, 2024

  • HGH:NZX
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (NZ$)

Section 1: Company Overview and Fundamentals

1.1 Company Overview: Heartland Group Holdings Limited (NZX: HGH) is a financial services group with operations in New Zealand and Australia.

Kalkine’s Investor Report covers the Key Financial Metrics, Risks, Outlook, Technical Analysis along with the Valuation, Target Price, and Recommendation on the stock.

1.2 The Key Positives, Negatives, Investment Highlights and Risks

1.2 Top 10 Shareholders: The top 10 shareholders have been highlighted in the chart, which together form ~21.0% of the total shareholding.

 

1.4 Key Metrics:

HGH posted a net interest margin of 3.67% in H1 FY 2024. Following are some other metrics:

Section 2: Financial Highlights and Recent Update

2.1 Key Business Update

2.1 Financial Highlights:

Section 3: Key Risks and Outlook:

3.1 Dividend History:

HGH approved the fully imputed interim dividend of 4 cents per share on 26th February 2024.

Section 4: Stock Recommendation Summary:

The stock has witnessed a fall of ~12.4% in 3 months. HGH was last covered on “20th June 2024.”

HGH Daily Technical Chart, Data Source: REFINITIV

4.1 Recommendation

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is neither an indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is July 15, 2024. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

 Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

Stop-loss: It is a level to protect further losses in case of unfavorable movement in the stock prices.


Disclaimer-

Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.

Past performance is not a reliable indicator of future performance.